Fast, casual Mediterranean restaurant CAVA will open its doors at Block 59 on Monday, Jan. 12, marking its first location in ...

From Irish Coffee to cherry liquor, explore luxe boozy fragrances that smell like a night out in a bottle. They are unique, ...

In her Tuesday newsletter, Lily Belli notes a reshuffling at downtown Santa Cruz's Abbott Square Market, reviews the new ...

Eli Lilly has shown patients maintained most of their weight loss after switching from injectable GLP-1s to its oral drug candidate, teeing the drugmaker up to target people taking Novo Nordisk’s ...

Eli Lilly's next-gen anti-obesity candidate hit it out of the park in a phase 3 study. This should help solidify the company's lead in this niche of the industry. Even after their strong run, Lilly's ...

Orforglipron maintains weight loss after switching from injectable GLP-1 drugs Lilly and Novo Nordisk await U.S. regulatory approvals for weight-loss pills FDA may expedite review of Lilly's ...

Its lineup and pipeline put it well ahead of even its closest competitor. The drugmaker should continue riding this wave for the foreseeable future. Furthermore, Novo Nordisk is anticipating ...

Eli Lilly (LLY) submitted an FDA application for orforglipron. The once-daily oral pill maintained weight loss after patients switched from injections. Lilly’s Zepbound achieved 20.2% average weight ...

What To Know: Novo Nordisk, one of Eli Lilly’s main competitors, announced a regulatory breakthrough for an oral weight loss drug. The FDA approved the company’s pill form of Wegovy, making it the ...

In the latest weekly data update, Eli Lilly's quality score advanced from 89.66 to 90.04. This uptick pushes the stock into the “elite” tier of the market, ranking it higher than 90% of its peers.

Lily Collins was born into the entertainment world. She made her film debut in The Blind Side in 2009 and later earned a Golden Globe nomination for Warren Beatty’s Rules Don’t Apply in 2016. She went ...